BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Consortium for Data Science - ECPv6.5.0.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Consortium for Data Science
X-ORIGINAL-URL:https://datascienceconsortium.org
X-WR-CALDESC:Events for The National Consortium for Data Science
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230822T120000
DTEND;TZID=America/New_York:20230822T130000
DTSTAMP:20260427T204536
CREATED:20230619T140554Z
LAST-MODIFIED:20230816T162023Z
UID:10000061-1692705600-1692709200@datascienceconsortium.org
SUMMARY:DataBytes: AI in Target Identification and Drug Discovery: Transforming the Future of Medicine
DESCRIPTION:The National Consortium for Data Science looks forward to hosting Kimberly Robasky\, Associate Director of Machine Learning/AI at Arrakis Therapeutics\, on August 22 for our next DataBytes event as she discusses AI in Target Identification and Drug Discovery: Transforming the Future of Medicine. \nRegister Here \nArtificial intelligence (AI) is taking a transformative role in target identification and drug discovery. Today\, AI algorithms can analyze vast\, multi-modal datasets to identify drug targets\, accelerate lead compound discovery\, and optimize drug design. AI is being used by biotechnology companies around the world to compress timelines and improving clinical trial outcomes. Join us to uncover the data-driven revolution in personalized medicine enabled by AI-driven drug development.
URL:https://datascienceconsortium.org/event/databytes-aug-2023/
LOCATION:via Zoom
ATTACH;FMTTYPE=image/png:https://datascienceconsortium.org/wp-content/uploads/NCDS_Flyer_2023_08_DataBytes_Small-Flyer.png
END:VEVENT
END:VCALENDAR